AP4 promotes HCC cell proliferation, migration, and invasion through activation of the PI3K/AKT signaling and caspase-dependent pathways and reduces chemosensitivity through LAPTM4B. This evidence concerns the gene AKT1 and hepatocellular carcinoma.